Website stats for Ymabs - ymabs.com
OverviewY-mAbs Therapeutics, Inc (Y-mAbs) is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets based on a range of technologies licensed from Memorial Sloan Kettering Cancer Center (“MSK”) under an exclusive worldwide license and research collaboration agreement. Y-mAbs applies its world-class antibody capabilities to create life-changing immuno...
ymabs.com was registered 1 decade 1 year ago. It has a alexa rank of #1,724,927 in the world. It is a domain having .com extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, ymabs.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 508 |
| Daily Pageviews: | 1,016 |
Estimated Valuation
| Income Per Day: | $ 3.00 |
| Estimated Worth: | $ 720.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 1,724,927 |
| PageSpeed Score: | 88 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
194.150.113.94
Hosted Country:
DK
Location Latitude:
56.4667Location Longitude:
10.05Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | 44.26% |
| Referral Traffic: | 9.56% |
| Search Traffic: | 46.18% |
| Social Traffic: | 0% |
| Mail Traffic: | 0% |
| Display Traffic: | 0% |
Search Engine Results For ymabs.com
Y-mAbs Therapeutics, Inc. | Home
Y-mAbs Therapeutics, Inc. (Y-mAbs), is a state-of-the-art, late-stage clinical, global biopharmaceutical company that is focused on the research and development of innovative...
Y-mAbs Therapeutics, Inc. (YMAB) - Yahoo Finance - Stock ...
YmAbs Therapeutics, Inc. (YMAB) Q3 2020 Earnings Call Transcript. Let me quickly remind you that the following discussion contains certain statements that are considered...
Y-mAbs Announces FDA Clearance of IND for its Lutetium-177 ...
Oct 14, 2020 · E-mail: [email protected]. Related Articles. More articles issued by Y-mAbs Therapeutics, Inc. More articles related to: Company Announcement. Profile. Y-mAbs...
Ymabs Therapeutics, Inc. - YMAB - Stock Price Today - Zacks
Nov 16, 2020 · View YmAbs Therapeutics, Inc. YMAB investment & stock information. Get the latest YmAbs Therapeutics, Inc. YMAB detailed stock quotes, …
Y-Mabs Therapeutics, Inc. - YMAB - Stock Price & News ...
YmAbs Therapeutics, Inc. (YMAB) Q4 2019 Earnings Call Transcript Motley Fool Transcribers | Mar 13, 2020 YMAB earnings call for the period ending December 31, 2019.
YmAbs Therapeutics, Inc. (YMAB) Q3 2020 Earnings Call ...
Nov 06, 2020 · YmAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2020 Earnings Call Nov 6, 2020, 9:00 a.m. ET Contents: Prepared Remarks; Questions and Answers; Call Participants;...
Y-mAbs Therapeutics, Inc. (YMAB) Latest Stock News ...
YmAbs Therapeutics, Inc. (YMAB) Q3 2020 Earnings Call Transcript. Let me quickly remind you that the following discussion contains certain statements that are considered...
YMAB - Y-mAbs Therapeutics Inc. • BioPharmCatalyst
NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB) a development-stage clinical biopharmaceutical company focused on...
Y-mAbs Therapeutics - Crunchbase Company Profile & Funding
YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients through immunotherapies. YmAbs utilizes its platform...
Y-mAbs’ Nivatrotamab for the Treatment of Patients with ...
Oct 07, 2020 · E-mail: [email protected]. Related Articles. More articles issued by Y-mAbs Therapeutics, Inc. More articles related to: Health Product / Services Announcement....
Y mAbs Therapeutics : mAbs Announces FDA Clearance of IND ...
NEW YORK, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the...
YmAbs Therapeutics, Inc. (YMAB) Q3 2020 Earnings Call ...
Nov 06, 2020 · YmAbs Therapeutics, Inc. (YMAB) Q3 2020 Earnings Call Transcript. Contributor. Motley Fool Transcribers The Motley Fool Published. Nov 6, 2020 …
Y mAbs Therapeutics : mAbs Announces Update on Naxitamab ...
NEW YORK - Y-mAbs Therapeutics, Inc. (the 'Company' or 'Y-mAbs') (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization...
Y-mAbs Therapeutics Inc. Stock Price (YMAB) | Barron's
View today's stock price, news and analysis for Y-mAbs Therapeutics Inc. (YMAB). Barron's also provides information on historical stock ratings, target prices, company earnings,...
Y-mAbs Therapeutics Inc (YMAB) Quote | Morningstar
[email protected]. www.ymabs.com Sector Healthcare. Industry Biotechnology. Most Recent Earnings Sep 30, 2020. Fiscal Year End Dec 31, 2019. Stock Type Distressed. Employees 65....
Y-mAbs Therapeutics, Inc. Common Stock (YMAB) - Nasdaq
Y-mAbs Therapeutics, Inc. Common Stock (YMAB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Y-mAbs - HBM Partners AG
YmAbs is a clinical stage biotechnology company specialized in developing novel antibody therapeutics to treat cancer. Several ongoing late-stage clinical trials significantly...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | Not Applicable |
| H3 Headings: | Not Applicable | H4 Headings: | 9 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 2 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-93568956-1 |
Websites Hosted on Same IP (i.e. 194.150.113.94)
RetroHjem | Retro & dansk design møbler - Luksus Genbrug Viborg
Retrohjem sælger retro møbler fra 50'ern, 60'erne & 70'erne | Stort udvalg af smukke genbrugsmøbler, dansk design & brugskunst - Se vores møbler --> HER!
7,691,387 
$ 240.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Wed, 04 Sep 2019 20:29:03 GMT
Server: Apache
X-Powered-By: PHP/5.5.9-1ubuntu4.22
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Vary: Accept-Encoding
Content-Encoding: gzip
Content-Length: 5733
Content-Type: text/html
Domain Information
| Domain Registrar: |
Key-Systems GmbH
|
|---|---|
| Registration Date: | 2013-09-06 1 decade 1 year 2 months ago |
| Last Modified: | 2019-08-09 5 years 3 months 1 week ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| guy.ns.cloudflare.com | |
108.162.193.173 |  United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| ymabs.com | A | 290 |
IP: 194.150.113.94 |
| ymabs.com | NS | 86400 |
Target: guy.ns.cloudflare.com |
| ymabs.com | NS | 86400 |
Target: lia.ns.cloudflare.com |
| ymabs.com | SOA | 3600 |
MNAME: guy.ns.cloudflare.com RNAME: dns.cloudflare.com Serial: 2031180997 Refresh: 10000 Retry: 2400 Expire: 604800 |
| ymabs.com | MX | 300 |
Priority: 10 Target: ymabs-com.mail.protection.outlook.com |
| ymabs.com | TXT | 300 |
TXT: ca3-805fbfa7507e437b9a3285bfd55bd0c5 |
| ymabs.com | TXT | 300 |
TXT: MS=ms80870919 |
| ymabs.com | TXT | 300 |
TXT: v=spf1 ip4:185.85.7.112 include:spf.protection.outlook.com -all |
Top Organic Keyword
| 1. | y-mabs therapeutics |
| 2. | mabs therapeutics |
| 3. | y mab |
| 4. | y-mabs |
| 5. | omburtamab neuroblastoma |
Top Paid Keyword
| Not Applicable |
Full WHOIS Lookup
Registry Domain ID:
1825996300_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.rrpproxy.net
Registrar URL:
http://www.key-systems.net
Updated Date:
2019-08-09T09:00:20Z
Creation Date:
2013-09-06T11:44:29Z
Registry Expiry Date:
2021-09-06T11:44:29Z
Registrar: Key-Systems GmbH
Registrar
IANA ID: 269
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+49.68949396850
Domain Status: ok
https://icann.org/epp#ok
Name Server:
GUY.NS.CLOUDFLARE.COM
Name Server:
LIA.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-09-04T20:29:00Z
Similarly Ranked Websites
ЦСКА - ОФИЦИАЛЕН САЙТ
ЦСКА • ОБЕДИНЕНИ СПОРТНИ КЛУБОВЕ ★ НОВИНИ ФЕН ЗОНА БИЛЕТИ И КАРТИ ЦСКА TV АЗ ♥ ЦСКА
1,725,019 $ 720.00
Bienvenido
Fabricantes Alemanes de lubricantes, aceites de motor, aditivos, productos para el cuidado del automóvil, reparación química además de productos de servicio, adhesivos y sellantes.
1,725,022 $ 720.00